Venlafaxine Augmentation in Treatment Resistant Depression

NCT00253266 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Depression

Interventions

DRUG: Venlafaxine
DRUG: Quetiapine

Sponsor

Max-Planck-Institute of Psychiatry